Director, Precision Vaccines Program; Principal Investigator; Staff Physician; Professor of Pediatrics
Cited in UK press coverage of health & social care
2 citations
Across 1 topic, first on 12 Aug 2026, most recently 27 Aug 2026.
Ofer Levy, MD, PhD, is a physician-scientist and board-certified paediatric infectious disease specialist who directs the Precision Vaccines Program at Boston Children's Hospital and holds a professorship in Paediatrics at Harvard Medical School, and is an Associate Member of the Broad Institute of MIT and Harvard. The Precision Vaccines Program applies precision medicine principles to vaccinology, conducting basic and translational research to develop next-generation vaccines and therapeutics tailored to vulnerable populations including infants, older adults, and the immunocompromised. Levy received his MD and PhD from New York University and completed his paediatric residency and fellowship in Infectious Diseases at Boston Children's Hospital. He served as a voting member of the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee (VRBPAC), participating in the Emergency Use Authorisation and approval of COVID-19 vaccines. He has more than 200 publications and a Google Scholar H-index of 74, and has been quoted in international media including the BBC, the New York Times, and Scientific American on vaccine policy and immunology.
Cited on
Stated areas of expertise
“This association with long COVID is an interesting finding as millions around the world suffer from this chronic condition. Having new insight as to the molecular and viral associations with long COVID could point the way to better understanding and ultimately better diagnostics and treatments.”
MD, PhD, director of the Precision Vaccines Program at Boston Children's · Long Covid · 27 Aug 2026 · COVID-19 awakens dormant viruses — and one is linked to long COVID ↗
“Although many no longer think of COVID being a problem, up to 50,000 Americans died of COVID in [the] 2025-2026 respiratory season and some estimates suggest over 10 million U.S. adults suffer from long COVID. We need to help these patients recover with the best outcomes.”
MD, PhD, principal investigator at Boston Children's Hospital · Long Covid · 12 Aug 2026 · Severe COVID may awaken dormant viruses, leading to autoimmune disease, long COVID ↗
Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.